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Abstract
Background: Anemia remains an important risk factor which contributes towards the worsening of the
outcomes, consisting of cardio-renal anemia syndrome and its impact in heart failure remains to be complex and
multifactorial. The current study was done to evaluate the role of anemia on mortality among patients having
congestive heart failure. Material and methods: This study included a total of 115 patients with congestive
heart failure presenting at Chaudhry Pervez Elahi Institute of Cardiology (CPEIC) Multan. After the inclusion of
patients in study, 3 ml of venous blood sample was drawn under aseptic conditions and immediately transported
to the hospital laboratory in EDTA vial for hemoglobin levels analysis. These patients were followed till
discharge to document in-hospital mortality during current hospitalization. All the sociodemographic distribution
and other relevant information such as age, gender, area of residence, diabetes, hypertension, obesity, smoking,
hyperlipidemia and mortality were noted in the proforma and data was entered and analyzed by SPSS version 22
for descriptive statistics and tests of significance. Anemia was cross-tabulated against in-hospital mortality using
two by two table and chi-square test was applied at level of significance of 0.05. Results: Among our 115
patients with congestive heart failure, 75 (65.2%) were males and 40 (34.8%) were females. Mean age of our
patients with CHF was 57.17 ± 11.65 years ranging from 34 to 80 years. Although males were younger than
female patients with congestive heart failure but this difference was not statistically significant (p=0.140).
Seventy five (65.2%) were from rural areas, 40 (34.8%) were poor, 70 (60.9%) from middle income families and
only 5 (4.3%) belonged to rich families. Forty five (39.1%) had diabetes and 55 (47.8%) had hypertension. Mean
body mass index (BMI) of patients with congestive heart failure was 26.12 ± 2.93 kg/m2 and 35 (30.4%) were
obese. Twenty five (21.7%) were smokers. Mean hemoglobin level of these patients was 11.36 ± 2.55 d/dl
ranging from 6.6 to 14.7 g/dl and anemia was documented in 60 (52.2%) our patients. In-hospital mortality in
patients with congestive heart failure was 12 (10.4%) and of these 12 mortalities, severe anemia was noted in 7
(58.33%) patients. Conclusion: Our study results have documented high frequency of anemia among patients
with congestive heart failure. In-hospital mortality was significantly associated with anemia and its severity.
Hemoglobin levels were significantly less among patients with in-hospital mortality compared with those who
were alive. Our study results suggest early diagnosis anemia followed by timely management can help to
decrease adverse events among patients with congestive heart failure.
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Introduction:
Cardiovascular diseases are the leading cause of mortality all over the world 1-3, particularly in developing
countries as the mortality rates among developed nations have dropped down significantly due to the availability
of the healthcare facilities and advancements in techniques owing to patient care 4-5. Heart failure is associated
with significant medical, financial, psychological and societal burden with high rates of emergency department
admissions6. In USA, due to the heart failure (as a primary or secondary diagnosis), approximately more than 2.6
million patients get hospitalized every year and increase cost of healthcare budget enormously 7. Congestive
heart failure is a common health issue with high rates of mortality, emergency department/hospital admissions,
reduced physical activity, poor productivity, loss of work and poor quality of life of the patients 8-10. There are
other modifiable as well as non-modifiable factors which lead to the worsening of the conditions of the patient
and poor prognosis in addition to direct impact of congestive heart failure 11-13. Anemia is also a major cause of
disease morbidity, poor quality of life and productivity, reduced physical activity and is common entity among
heart failure patients, hence representing a modifiable risk factor for poor prognosis and adverse clinical
outcomes. It is also a strong predictor for the burden of related co-morbidities and for increased severity of the
disease.
Anemia remains an important risk factor which contributes towards the worsening of the outcomes,
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consisting of cardio-renal anemia syndrome and its impact in heart failure remains to be complex and
multifactorial 13. Among patients having heart failure, causes of anemia may include “nutritional deficiencies
(malabsorption, impaired metabolism), acute blood loss (gastrointestinal bleeding), decrease in erythropoietin
production and response to erythropoietin due to the intrinsic renal disease, hemodilution because of volume
expansion, relative iron deficiency, chronic disease anemia, etc. advanced age, the presence of DM and renal
failure are associated with anemia”.14Khan et a l11 reported 43% anemia in patients with congestive heart failure
(CHF), Oster et al15 reported 55 % anemia in patients with CHF. The mortality rate in patients with the anemia
group was 8.6% 16, Kuule et al17 reported 7.5 ± 3.4 days hospital stay for these patients.
Owing to role of anemia in congestive heart failure in worsening of the condition and poor prognosis of the
patients, this study was conducted to evaluate role of anemia in CHF in Southern Punjab. This study was done to
determine the role of anemia associated with mortality to generate evidence on this topic as there is limited data
on this topic from Pakistan.
Material and methods:
This study included a total of 115 patients with congestive heart failure presenting at Chaudhry Pervez Elahi
Institute of Cardiology (CPEIC) Multan. Congestive Heart failure patients more than 20 years of age were
included and CHF was defined as “patients having shortness of breath having Killip class I-IV (class I=no
cracles, class II=JVP, class III=pulmonary edema, class IV=cardiogenic shock) and swelling of legs (assessed on
clinical judgment by 2-3 minutes pressing of medial malleolus, if pit develops it was taken as positive) for more
than 1 month (presence of all) which is consistent with echocardiographic findings (percentage of blood ejected
with each beat – less than 50 – 75%” while patients having any malignancy, chronic obstructive pulmonary
disease, poor intake and CABG were excluded. After the inclusion of patients in study, 3 ml of venous blood
sample was drawn under aseptic conditions and immediately transported to the hospital laboratory in EDTA vial
for hemoglobin levels analysis. Anemia was defined as “if Hb level is less than 13 g/dl for men and 12 g/dl for
females”, mild anemia was defined as “Hb 10 - 11.9 g/dl for women and 10 - 12.9 g/dl for men”, moderate
anemia was defined as “Hb levels ranging from 7 - 9.9 g/dl for both genders” and severe anemia was defined as
“Hb values <7 g/dl for both genders”. These patients were followed till discharge to document in-hospital
mortality during current hospitalization. All the sociodemographic distribution and other relevant information
such as age, gender, area of residence, diabetes, hypertension, obesity, smoking, hyperlipidemia and mortality
were noted in the proforma and data was entered and analyzed by SPSS version 22 for descriptive statistics and
tests of significance. Anemia was cross-tabulated against in-hospital mortality using two by two table and chi-
square test was applied at level of significance of 0.05.
Results:
Among our 115 patients with congestive heart failure, 75 (65.2%) were males and 40 (34.8%) were females.
Mean age of our patients with CHF was 57.17 ± 11.65 years ranging from 34 to 80 years. Although males were
younger than female patients with congestive heart failure but this difference was not statistically significant
(p=0.140). Seventy five (65.2%) were from rural areas, 40 (34.8%) were poor, 70 (60.9%) from middle income
families and only 5 (4.3%) belonged to rich families. Forty five (39.1%) had diabetes and 55 (47.8%) had
hypertension. Mean body mass index (BMI) of patients with congestive heart failure was 26.12 ± 2.93 kg/m2 and
35 (30.4%) were obese. Twenty five (21.7%) were smokers. Mean hemoglobin level of these patients was 11.36
± 2.55 d/dl ranging from 6.6 to 14.7 g/dl and anemia was documented in 60 (52.2%) our patients. In-hospital
mortality in patients with congestive heart failure was 12 (10.4%) and of these 12 mortalities, severe anemia was
noted in 7 (58.33%) patients. The role of anemia on mortality rate in patients with CHF has been presented in
Table No. 1.
Table No. 1
Distribution of in-hospital mortality compared with anemia.
(n=115)
Anemia
Mortality
P – valueYes
(n = 12)
No
(n = 103)
Yes
(n = 60)
10 50
0.031
No
(n = 55)
02 53
Total 115
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Table No. 2
Distribution of mean Hb levels with in-hospital mortality.
Hemoglobin level
Mortality
P – valueYes
(n = 12)
No
(n = 103)
Mean 8.51 11.69
0.001
SD 3.08 2.27
Table No. 3
Distribution of in-hospital mortality with different factors.
(n=115)
Characteristic
Mortality
P – value
Yes No
Gender
Male 07 68
0.750
Female 05 35
Age groups
Up to 50 Years 06 39
0.534
> 50 Years 06 64
Residential status
Rural 10 65
0.212
Urban 02 38
Diabetes
Yes 06 39
0.534
No 06 64
Socioeconomic
status
Poor 02 38
0.228Middle Income 10 60
High income 00 05
Hypertension
Yes 11 44
0.005
No 01 59
Obesity
Yes 02 33
0.340
No 10 70
Smoking
Yes 04 21
0.290
No 08 82
Discussion:
Anemia remains an important risk factor which contributes towards the worsening of the outcomes, consisting of
cardio-renal anemia syndrome and its impact in heart failure remains to be complex and multifactorial. Among
our 115 patients with congestive heart failure, 75 (65.2%) were males and 40 (34.8%) were females. Silverberg
et al 18 documented 79 % male patients having congestive heart failure, in compliance with our study results. Dai
et al 19 has also reported similar results. Rasheed et al 20 reported 88% male patients with congestive heart failure
showing compliance with our findings. Khan et al 21 reported 60 % male gender predominance in patients with
CHF which are close to our study results. Nasir et al 22 reported male gender preponderance with 65 % which is
close to our study results.
Mean age of our patients with CHF was 57.17 ± 11.65 years ranging from 34 to 80 years. Although males
were younger than female patients with congestive heart failure but this difference was not statistically
significant (p=0.140). Rasheed et al 20 reported 50.77 ± 7.53 years mean age which is close to our study results.
Nasir et al 22 reported 60 ± 13 years mean age which is similar to that of our study results. Vim et al 23 from Iran
also reported 61 years mean age of the patients with congestive heart failure (CHF) which is close to our study
results.
Seventy five (65.2%) were from rural areas, 40 (34.8%) were poor, 70 (60.9%) from middle income
families and only 5 (4.3%) belonged to rich families. Forty five (39.1%) had diabetes and 55 (47.8%) had
hypertension. Mean body mass index (BMI) of patients with congestive heart failure was 26.12 ± 2.93 kg/m2 and
35 (30.4%) were obese. Twenty five (21.7%) were smokers. Silverberg et al 18 reported diabetes in 30 %,
hypertension in 64% and smoking in 40 % patients. These findings are close to our study results. Dai et al 19
reported similar results.
Mean hemoglobin level of these patients was 11.36 ± 2.55 d/dl ranging from 6.6 to 14.7 g/dl and anemia
was documented in 60 (52.2%) our patients. In-hospital mortality in patients with congestive heart failure was 12
(10.4%) and of these 12 mortalities, severe anemia was noted in 7 (58.33%) patients and there was significant
association with severity of anemia.
Silverberg et al 18 reported 79.1 % frequency of anemia which shows high frequency of anemia in
compliance with our findings. Usmanov et al 24 reported 10.7 ± 0.4 mg/dl mean Hb level in CHF which is in
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compliance with our study results. Dai et al 19 reported 62.2 % anemia in CHF which is similar to that of our
study results. Khan et al 11 reported 43% anemia in patients with congestive heart failure (CHF), Oster et al 15
reported 55 % anemia in patients with CHF which is close to our results. Kuule et al 17 reported 7.5 ± 3.4 days
hospital stay for these patients, these findings are in compliance with our study results. Mortality was noted in 16
(8.5%) of our study cases. Dai et al 19 reported mortality in 6.3 % in CHF with anemia which is close to our
study results.
Conclusion:
Our study results have documented high frequency of anemia among patients with congestive heart failure. In-
hospital mortality was significantly associated with anemia and its severity. Hemoglobin levels were
significantly less among patients with in-hospital mortality compared with those who were alive. Our study
results suggest early diagnosis anemia followed by timely management can help to decrease adverse events
among patients with congestive heart failure.
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